CRISPR Therapeutics AG - Common Stock (CRSP)

Historical Holders from Q1 2016 to Q3 2025

Symbol: CRSP on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 90,438,636
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 72,221,553
Holdings value: $4,679,760,423
% of all portfolios: 0.009%
Number of holders: 429
Number of buys: 214
Number of sells: -176
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CRISPR Therapeutics AG - Common Stock (CRSP)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ARK Investment Management LLC	10.76%	-9.1%	$634,293,720	-$24,525,854	9,786,973	-3.7%	ARK Investment Management LLC	30 Sep 2025
Capital International Investors	7.4%		$236,896,911		6,334,142		Capital International Investors	31 Mar 2025
BlackRock, Inc.	6.9%		$288,553,541		5,932,433		BlackRock, Inc.	30 Jun 2025
ORBIS INVESTMENT MANAGEMENT LTD	5.5%		$322,373,041		4,974,125		ORBIS INVESTMENT MANAGEMENT LTD	30 Sep 2025

Institutional Holders of CRISPR Therapeutics AG - Common Stock (CRSP)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	72,221,553	$4,679,760,423	+$28,335,506	$200,755,456	$222,506,210	$64.81	429
2025 Q2	72,314,703	$3,517,677,257	+$428,897,837	$108,846,272	$172,992,116	$48.64	426
2025 Q1	64,129,300	$2,183,568,653	-$16,834,672	$65,142,487	$69,911,674	$34.03	388
2024 Q4	64,443,699	$2,536,549,693	+$179,624,639	$75,688,021	$60,260,334	$39.36	398
2024 Q3	59,826,628	$2,811,325,020	+$6,501,203	$89,092,012	$49,827,610	$46.98	407
2024 Q2	59,510,276	$3,214,159,736	+$50,043,500	$98,352,210	$91,865,415	$54.01	439
2024 Q1	57,288,998	$3,904,937,558	+$217,314,654	$166,828,304	$195,924,509	$68.16	469
2023 Q4	55,520,285	$3,475,779,179	+$42,550,297	$241,341,580	$197,441,452	$62.6	465
2023 Q3	54,993,134	$2,496,662,136	-$1,898,845	$61,176,642	$58,721,043	$45.39	400
2023 Q2	54,718,539	$3,071,120,295	-$80,853,798	$85,766,066	$95,640,372	$56.14	409
2023 Q1	56,199,828	$2,540,792,585	+$38,754,979	$58,742,526	$54,008,697	$45.23	375
2022 Q4	55,494,852	$2,255,613,450	-$74,822,214	$70,165,700	$76,503,010	$40.65	386
2022 Q3	56,683,321	$3,701,432,142	-$78,744,860	$152,085,980	$161,424,055	$65.35	410
2022 Q2	55,502,675	$3,344,489,851	+$271,662,077	$114,090,296	$128,380,176	$60.77	404
2022 Q1	49,481,600	$3,107,777,604	+$483,746,495	$117,770,050	$119,323,782	$62.77	415
2021 Q4	42,884,873	$3,253,105,466	+$73,035,179	$148,329,000	$148,175,050	$75.78	425
2021 Q3	40,405,115	$4,522,264,525	-$41,114,506	$304,636,862	$175,712,000	$111.93	458
2021 Q2	40,533,549	$6,560,272,742	-$153,120,996	$433,471,281	$365,204,000	$161.89	484
2021 Q1	42,643,720	$5,195,793,257	-$576,803,869	$285,814,400	$240,289,730	$121.85	431
2020 Q4	47,170,730	$7,222,892,447	+$35,286,644	$212,888,000	$209,200,000	$153.11	397
2020 Q3	47,858,309	$4,002,814,216	+$723,322,979	$59,741,000	$56,705,000	$83.64	300
2020 Q2	38,277,395	$2,809,424,935	+$279,188,892	$81,083,000	$68,146,585	$73.49	263
2020 Q1	35,534,767	$1,506,022,854	+$153,360,658	$27,613,000	$37,634,000	$42.41	244
2019 Q4	31,537,408	$1,920,718,365	+$255,276,153	$51,782,000	$35,190,000	$60.9	248
2019 Q3	27,534,073	$1,131,426,201	-$8,297,966	$17,577,000	$20,362,000	$40.99	176
2019 Q2	27,401,117	$1,290,347,942	+$107,556,651	$22,132,000	$26,532,000	$47.1	176
2019 Q1	26,007,044	$928,966,936	+$146,098,285	$20,032,000	$11,057,000	$35.72	163
2018 Q4	22,084,355	$630,914,836	-$57,784,767	$15,119,000	$7,386,000	$28.57	151
2018 Q3	22,857,503	$1,013,718,783	+$176,760,080	$38,730,000	$15,292,000	$44.35	171
2018 Q2	18,496,060	$1,086,865,478	-$651,038	$77,438,000	$25,150,000	$58.76	171
2018 Q1	18,718,531	$855,401,603	+$303,959,521	$26,046,000	$7,199,000	$45.71	132
2017 Q4	12,499,892	$293,264,477	+$61,797,532	$1,383,000	$3,214,000	$23.48	82
2017 Q3	10,055,642	$179,590,160	+$6,177,091	$952,000		$17.87	61
2017 Q2	9,694,198	$155,107,419	-$4,334,397	$322,000		$16.02	36
2017 Q1	9,693,488	$210,826,092	-$2,609,245			$21.77	36
2016 Q4	9,833,888	$197,779,000	+$197,766,000			$20.26	26
2016 Q2	0	$0	-$1,000				0
2016 Q1	40	$1,000				$25	1